Thyroid cancer

ME Cabanillas, DG McFadden, C Durante - The Lancet, 2016 - thelancet.com
… so that patients with lower risk disease or benign thyroid nodules are not over treated. At the
… -risk disease, who need a more aggressive treatment approach. Thyroid cancers exhibit a …

Thyroid cancer

T Carling, R Udelsman - Annual review of medicine, 2014 - annualreviews.org
… Given the low rates of both newly identified structural disease and morbidity after surgery for
PTC, prohibitively large sample sizes would be required to obtain sufficient statistical power …

… radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer

F Vaisman, A Shaha, S Fish… - Clinical …, 2011 - Wiley Online Library
thyroid cancer with a very low risk of structural disease recurrence following treatment with
either thyroid … support a selective approach to the initial management of thyroid cancer. …

Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American Thyroid Association and Latin American Thyroid Society risk of …

F Pitoia, F Bueno, C Urciuoli, E Abelleira, G Cross… - Thyroid, 2013 - liebertpub.com
thyroid cancer patients treated with total thyroidectomy and radioactive iodine at a single
experienced thyroid cancer … in the absence of structural disease), structural persistent disease (…

Follicular cell-derived thyroid cancer

H Dralle, A Machens, J Basa, V Fatourechi… - Nature reviews Disease …, 2015 - nature.com
… In thyroid cancer surgery, for instance, injuries to structures … papillary thyroid cancer (PTC),
follicular thyroid cancer (FTC), poorly … thyroid cancer and undifferentiated (anaplastic) thyroid

Time course and predictors of structural disease progression in pulmonary metastases arising from follicular cell–derived thyroid cancer

MM Sabra, R Ghossein, RM Tuttle - Thyroid, 2016 - liebertpub.com
… , progressive metastatic thyroid cancer, it becomes important to define the time course
and risk factors for structural disease progression in follicular cell–derived thyroid cancer (FCDTC) …

In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete …

F Vaisman, H Tala, R Grewal, RM Tuttle - Thyroid, 2011 - liebertpub.com
structural disease progression, and a much lower likelihood of dying from thyroid cancer than
patients exhibiting a structural … -up of 8 years, structural disease was present at the time of …

… to therapy status is an excellent predictor of pregnancy-associated structural disease progression in patients previously treated for differentiated thyroid cancer

L Rakhlin, S Fish, RM Tuttle - Thyroid, 2017 - liebertpub.com
… to evaluate the risk of structural disease recurrence and/or progression within each of the
response-to-therapy categories (excellent, biochemical incomplete, structural incomplete, and …

Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancer

M Klain, E Zampella, M Manganelli, V Gaudieri… - Endocrine, 2021 - Springer
… (two with N1a and three with N1b disease at diagnosis). The other … structural disease in
the neck that was located in the thyroid bed in four patients and in both lymph nodes and thyroid

[HTML][HTML] Differentiated thyroid cancer with biochemical incomplete response: clinico-pathological characteristics and long term disease outcomes

M Steinschneider, J Pitaro, S Koren, Y Mizrakli… - Cancers, 2021 - mdpi.com
… The American Thyroid Association (ATA) Initial Risk … predicted the shift from BIR to structural
disease, irrespective of their … to structural disease, and most have a rather indolent disease. …